Cargando…
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial
Sodium-glucose cotransporter 2 inhibitors improve outcomes in patients with heart failure with reduced ejection fraction, but additional information is needed about whether glycemic status influences the magnitude of their benefits on heart failure and renal events. METHODS: Patients with Class II–I...
Autores principales: | Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos, Khan, Muhammad Shahzeb, Marx, Nikolaus, Lam, Carolyn S.P., Schnaidt, Sven, Ofstad, Anne Pernille, Brueckmann, Martina, Jamal, Waheed, Bocchi, Edimar A., Ponikowski, Piotr, Perrone, Sergio V., Januzzi, James L., Verma, Subodh, Böhm, Michael, Ferreira, João Pedro, Pocock, Stuart J., Zannad, Faiez, Packer, Milton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834911/ https://www.ncbi.nlm.nih.gov/pubmed/33175585 http://dx.doi.org/10.1161/CIRCULATIONAHA.120.051824 |
Ejemplares similares
-
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
por: Butler, Javed, et al.
Publicado: (2021) -
Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
por: Packer, Milton, et al.
Publicado: (2021) -
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled
por: Ferreira, João Pedro, et al.
Publicado: (2022) -
Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR‐Reduced trial
por: Packer, Milton, et al.
Publicado: (2021) -
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial( )
por: Doehner, Wolfram, et al.
Publicado: (2022)